Alpha 2.0
Login Register
» Articles » PMID: 2895392

IgG Subclass Deficiency and Chronic Fatigue Syndrome

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1988 Apr 16
PMID 2895392
Citations 6
Authors
A Linde
L Hammarstrom
C I Smith
Affiliations
Soon will be listed here.
Citing Articles

Back to the Future? Immunoglobulin Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Brownlie H, Speight N Healthcare (Basel). 2021; 9(11).

PMID: 34828592 PMC: 8623195. DOI: 10.3390/healthcare9111546.

Epstein-Barr Virus Induced Gene-2 Upregulation Identifies a Particular Subtype of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Kerr J Front Pediatr. 2019; 7:59.

PMID: 30918887 PMC: 6424879. DOI: 10.3389/fped.2019.00059.

Antibody response to the Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in healthy and infection-prone individuals with IgG3 subclass deficiency.

Hahn-Zoric M, Ulanova M, Friman V, Bjorkander J, Oxelius V, Lucas A J Clin Immunol. 2004; 24(5):561-70.

PMID: 15359115 DOI: 10.1023/B:JOCI.0000040927.15641.0c.

Immunoglobulin subclass levels in chronic fatigue syndrome.

Bennett A, Fagioli L, Schur P, Schacterle R, Komaroff A J Clin Immunol. 1996; 16(6):315-20.

PMID: 8946275 DOI: 10.1007/BF01541666.

Treatment of the chronic fatigue syndrome. A review and practical guide.

Blondel-Hill E, Shafran S Drugs. 1993; 46(4):639-51.

PMID: 7506650 DOI: 10.2165/00003495-199346040-00005.